Black Diamond Therapeutics (BDTX) Price to FCF (2020 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Price to FCF came in at 12.92 in Q2 2026, up 16.51% on a YoY basis from 11.09 in Q2 2025, and down 7.87% quarter-over-quarter from 11.98 in Q1 2026.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) Price to FCF (2020 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has reported Price to FCF for 7 consecutive years, with 12.92 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to FCF rose 16.51% year-over-year to 12.92; the trailing twelve-month figure through Jun 2026 stood at 3.22 (down 141.25% YoY), and the FY2025 full-year result was 4.66, up 340.51% from the prior year.
- Price to FCF eased to 12.92 in Q2 2026 per BDTX's latest filing, from 11.98 in the prior quarter.
- Across five years, Price to FCF topped out at 1.64 in Q1 2025 and bottomed at 27.65 in Q3 2025.
- Historically, Price to FCF has averaged 10.93 across 5 years, with a median of 11.19 in 2026.
- The sharpest annual moves came in 2025 and 2026: Price to FCF soared 113.08% in 2025, then slumped 828.96% in 2026.
- Over 5 years, Price to FCF stood at 2.99 in 2022, then slumped by 247.87% to 10.4 in 2023, then advanced by 22.34% to 8.08 in 2024, then slumped by 154.99% to 20.59 in 2025, then soared by 37.24% to 12.92 in 2026.
- According to Business Quant data, Price to FCF over the past three periods registered 12.92, 11.98, and 20.59 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Black Diamond Therapeutics | 111.58 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.92 |
| Mar 31, 2026 | -11.98 |
| Dec 31, 2025 | -20.59 |
| Sep 30, 2025 | -27.65 |
| Jun 30, 2025 | -15.48 |
| Mar 31, 2025 | 1.64 |
| Dec 31, 2024 | -8.08 |
| Sep 30, 2024 | -21.80 |
| Jun 30, 2024 | -17.45 |
| Mar 31, 2024 | -12.56 |
| Dec 31, 2023 | -10.40 |
| Sep 30, 2023 | -8.06 |
| Jun 30, 2023 | -12.84 |
| Mar 31, 2023 | -3.45 |
| Dec 31, 2022 | -2.99 |
| Sep 30, 2022 | -3.73 |
| Jun 30, 2022 | -4.89 |
| Mar 31, 2022 | -3.51 |
| Dec 31, 2021 | -7.92 |
| Sep 30, 2021 | -11.08 |